Lipid-lowering plan after heart attack in adults
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a cholesterol-lowering treatment plan for adults admitted for a Type 1 heart attack. It may help your care team choose guideline-based cholesterol goals and treatments after the event.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted for a Type 1 heart attack
- Your baseline LDL (“bad cholesterol”) must be at least 1.4 mmol/L
- You must be able to share contact details for your primary doctor (GP)
- You must be able to give written informed consent
- Your doctor should think you’re likely to live more than 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a new cholesterol-lowering drug, inclisiran, early during a hospital stay after a heart attack can help lower bad cholesterol (LDL) more effectively than usual care. It may reduce the risk of future heart problems.
This trial tests a new way to check heart risk and start treatment for cholesterol in people coming to the emergency room with chest pain or possible heart attack. It aims to see if early risk assessment and treatment can prevent future heart problems.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial tests whether a program that uses electronic health records can help people who have had a heart attack lower their LDL (bad) cholesterol more effectively. It aims to improve follow-up care and reduce the risk of future heart problems.
This study tests whether a team-based program (including diet, exercise, and medication management) helps people who have had a heart event lower their 'bad' cholesterol (LDL) more effectively than standard care. It may help reduce your risk of future heart problems.
This study tests a team-based approach to help people with artery disease (like heart attacks or leg blockages) get their cholesterol to a healthier level. If your LDL is above 70, you may benefit from extra support to manage your medications.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.